Work

The Role of Organoid‐Based Drug Sensitivity Testing in Clinical Cancer Therapy

Year: 2024

Type: editorial

Abstract: In recent years, cancer has become a significant global health burden, with rising incidence rates emphasizing the need for innovative therapeutic strategies. Among these, organoid models have emerged as transformative platforms, offering unprecedented insights into tumor biology, drug screening, and therapeutic responses. This editorial explores the evolving role of organoids in precision oncology, highlighting their potential to bridge the gap between preclinical research and personalized medicine.

Source: Organ medicine.

DOI: 10.1002/orm2.12

Authors: Huan Yang, Yuhong Liu, Jia Li, Yulong He, Leli Zeng, Yihang Pan

Institutions: The Seventh Affiliated Hospital of Sun Yat-sen University, Sun Yat-sen University

Language: English

Topic: Cancer Cells and Metastasis

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Funders: National Natural Science Foundation of China, Science and Technology Planning Project of Shenzhen Municipality